Asia-Pacific (APAC) Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Asia-Pacific (APAC) Biotechnology Market Summary, Competitive Analysis and Forecast to 2028


Summary

Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
  • The Asia-Pacific biotechnology market recorded revenues of $364.5 billion in 2023, representing a compound annual growth rate (CAGR) of 10.5% between 2018 and 2023.
  • The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $220.2 billion, equivalent to 60.4% of the market's overall value.
  • The Asia-Pacific biotechnology market is experiencing growth due to innovation and potential therapeutic developments. Government initiatives are driving growth in the industry, such as Japan's $3 billion investment in the Drug Development Venture Ecosystem Enhancement Project and China's emphasis on research and development.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts
Reasons to Buy
  • What was the size of the Asia-Pacific biotechnology market by value in 2023?
  • What will be the size of the Asia-Pacific biotechnology market in 2028?
  • What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Asia-Pacific's biotechnology market?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?
8 Company Profiles
8.1. Takeda Pharmaceutical Company Limited
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Astellas Pharma Inc.
8.4. Daiichi Sankyo Co Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Asia-Pacific biotechnology industry value: $ million, 2018-23
Table 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: Asia-Pacific biotechnology industry category segmentation: $ million, 2018-2023
Table 4: Asia-Pacific biotechnology industry geography segmentation: $ million, 2023
Table 5: Asia-Pacific biotechnology industry value forecast: $ million, 2023-28
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 11: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 12: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 13: Astellas Pharma Inc.: key facts
Table 14: Astellas Pharma Inc.: Annual Financial Ratios
Table 15: Astellas Pharma Inc.: Key Employees
Table 16: Daiichi Sankyo Co Ltd: key facts
Table 17: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 18: Daiichi Sankyo Co Ltd: Key Employees
Table 19: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 20: Asia-Pacific exchange rate, 2019-23
List of Figures
Figure 1: Asia-Pacific biotechnology industry value: $ million, 2018-23
Figure 2: Asia-Pacific biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: Asia-Pacific biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings